Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ferric citrate on mineral and iron metabolism in hemodialysis patients
jRCT1090220207Completed
- Sponsor
- Shigeru Miyazaki
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ferric citrate in end-stage kidney disease (ESKD) and hyperphosphatemia, sponsored by Shigeru Miyazaki. Primary endpoint: Serum concentration of Ca, P, iron regulatory factors. Started Jan 2015; status: completed.
02
Drugs
ferric citrate
03
Conditions
end-stage kidney disease (ESKD)hyperphosphatemia
Beyond the preview
Go deeper on jRCT1090220207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220207.